nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2A6—Methoxsalen—psoriasis	0.0905	0.119	CbGbCtD
Isoniazid—CYP2C8—Tazarotene—psoriasis	0.0692	0.0912	CbGbCtD
Isoniazid—CYP1A2—Clobetasol propionate—psoriasis	0.0657	0.0866	CbGbCtD
Isoniazid—CYP2A6—Prednisolone—psoriasis	0.044	0.058	CbGbCtD
Isoniazid—CYP1A2—Methoxsalen—psoriasis	0.0345	0.0455	CbGbCtD
Isoniazid—CYP2D6—Hydroxyurea—psoriasis	0.0311	0.041	CbGbCtD
Isoniazid—CYP2C8—Cholecalciferol—psoriasis	0.0295	0.0389	CbGbCtD
Isoniazid—CYP2A6—Dexamethasone—psoriasis	0.0259	0.0342	CbGbCtD
Isoniazid—CYP2C8—Mycophenolate mofetil—psoriasis	0.0256	0.0338	CbGbCtD
Isoniazid—CYP2C19—Cholecalciferol—psoriasis	0.0248	0.0327	CbGbCtD
Isoniazid—CYP3A4—Calcitriol—psoriasis	0.0233	0.0307	CbGbCtD
Isoniazid—CYP2C9—Cholecalciferol—psoriasis	0.0206	0.0272	CbGbCtD
Isoniazid—CYP2C8—Hydrocortisone—psoriasis	0.0206	0.0271	CbGbCtD
Isoniazid—CYP2C8—Cyclosporine—psoriasis	0.0194	0.0256	CbGbCtD
Isoniazid—CYP2D6—Cholecalciferol—psoriasis	0.0188	0.0248	CbGbCtD
Isoniazid—CYP3A4—Methoxsalen—psoriasis	0.0181	0.0238	CbGbCtD
Isoniazid—CYP2C19—Prednisone—psoriasis	0.0172	0.0226	CbGbCtD
Isoniazid—CYP2E1—Dexamethasone—psoriasis	0.0171	0.0226	CbGbCtD
Isoniazid—CYP2C19—Cyclosporine—psoriasis	0.0163	0.0215	CbGbCtD
Isoniazid—CYP2C9—Cyclosporine—psoriasis	0.0135	0.0178	CbGbCtD
Isoniazid—CYP2C8—Dexamethasone—psoriasis	0.0128	0.0169	CbGbCtD
Isoniazid—CYP2D6—Cyclosporine—psoriasis	0.0124	0.0163	CbGbCtD
Isoniazid—CYP3A4—Cholecalciferol—psoriasis	0.012	0.0158	CbGbCtD
Isoniazid—CYP2C19—Dexamethasone—psoriasis	0.0107	0.0141	CbGbCtD
Isoniazid—CYP3A4—Mycophenolate mofetil—psoriasis	0.0104	0.0137	CbGbCtD
Isoniazid—CYP3A4—Triamcinolone—psoriasis	0.0104	0.0137	CbGbCtD
Isoniazid—CYP2C9—Dexamethasone—psoriasis	0.00892	0.0118	CbGbCtD
Isoniazid—CYP3A4—Betamethasone—psoriasis	0.00891	0.0117	CbGbCtD
Isoniazid—CYP3A4—Prednisolone—psoriasis	0.0088	0.0116	CbGbCtD
Isoniazid—CYP3A4—Hydrocortisone—psoriasis	0.00834	0.011	CbGbCtD
Isoniazid—CYP3A4—Prednisone—psoriasis	0.00831	0.0109	CbGbCtD
Isoniazid—CYP2D6—Dexamethasone—psoriasis	0.00815	0.0107	CbGbCtD
Isoniazid—CYP3A4—Cyclosporine—psoriasis	0.00787	0.0104	CbGbCtD
Isoniazid—CYP3A4—Dexamethasone—psoriasis	0.00519	0.00683	CbGbCtD
Isoniazid—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00301	0.0634	CbGpPWpGaD
Isoniazid—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00238	0.0501	CbGpPWpGaD
Isoniazid—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00205	0.0433	CbGpPWpGaD
Isoniazid—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00186	0.0393	CbGpPWpGaD
Isoniazid—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00183	0.0387	CbGpPWpGaD
Isoniazid—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00169	0.0356	CbGpPWpGaD
Isoniazid—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00167	0.0353	CbGpPWpGaD
Isoniazid—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00157	0.0332	CbGpPWpGaD
Isoniazid—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00147	0.0311	CbGpPWpGaD
Isoniazid—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00127	0.0269	CbGpPWpGaD
Isoniazid—NAT2—Biological oxidations—CYP2S1—psoriasis	0.00124	0.0262	CbGpPWpGaD
Isoniazid—NAT2—Metapathway biotransformation—CYP2S1—psoriasis	0.00123	0.0258	CbGpPWpGaD
Isoniazid—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00114	0.024	CbGpPWpGaD
Isoniazid—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.00105	0.022	CbGpPWpGaD
Isoniazid—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00104	0.0219	CbGpPWpGaD
Isoniazid—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000886	0.0187	CbGpPWpGaD
Isoniazid—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000774	0.0163	CbGpPWpGaD
Isoniazid—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000764	0.0161	CbGpPWpGaD
Isoniazid—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000683	0.0144	CbGpPWpGaD
Isoniazid—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000628	0.0132	CbGpPWpGaD
Isoniazid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000612	0.0129	CbGpPWpGaD
Isoniazid—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000604	0.0127	CbGpPWpGaD
Isoniazid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000529	0.0112	CbGpPWpGaD
Isoniazid—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000522	0.011	CbGpPWpGaD
Isoniazid—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000496	0.0105	CbGpPWpGaD
Isoniazid—Discomfort—Acitretin—psoriasis	0.000496	0.00256	CcSEcCtD
Isoniazid—Rash—Beclomethasone—psoriasis	0.000489	0.00252	CcSEcCtD
Isoniazid—Neuropathy peripheral—Mycophenolic acid—psoriasis	0.000486	0.00251	CcSEcCtD
Isoniazid—Vasculitis—Prednisone—psoriasis	0.000486	0.00251	CcSEcCtD
Isoniazid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000485	0.0102	CbGpPWpGaD
Isoniazid—Rash—Fluocinonide—psoriasis	0.000485	0.0025	CcSEcCtD
Isoniazid—Jaundice—Mycophenolic acid—psoriasis	0.000483	0.00249	CcSEcCtD
Isoniazid—Body temperature increased—Methoxsalen—psoriasis	0.000479	0.00247	CcSEcCtD
Isoniazid—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000472	0.00995	CbGpPWpGaD
Isoniazid—Decreased appetite—Calcitriol—psoriasis	0.00047	0.00242	CcSEcCtD
Isoniazid—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000466	0.00982	CbGpPWpGaD
Isoniazid—Agranulocytosis—Mycophenolic acid—psoriasis	0.000463	0.00239	CcSEcCtD
Isoniazid—Nausea—Beclomethasone—psoriasis	0.000461	0.00238	CcSEcCtD
Isoniazid—Anorexia—Acitretin—psoriasis	0.000458	0.00237	CcSEcCtD
Isoniazid—Diabetes mellitus—Dexamethasone—psoriasis	0.000454	0.00234	CcSEcCtD
Isoniazid—Diabetes mellitus—Betamethasone—psoriasis	0.000454	0.00234	CcSEcCtD
Isoniazid—Psychotic disorder—Hydrocortisone—psoriasis	0.000452	0.00233	CcSEcCtD
Isoniazid—Hypersensitivity—Methoxsalen—psoriasis	0.000447	0.00231	CcSEcCtD
Isoniazid—Hepatitis—Mycophenolic acid—psoriasis	0.000445	0.0023	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—psoriasis	0.000436	0.00225	CcSEcCtD
Isoniazid—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000434	0.00916	CbGpPWpGaD
Isoniazid—Paraesthesia—Acitretin—psoriasis	0.000432	0.00223	CcSEcCtD
Isoniazid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00043	0.00908	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Hydroxyurea—psoriasis	0.000429	0.00221	CcSEcCtD
Isoniazid—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000429	0.00904	CbGpPWpGaD
Isoniazid—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000428	0.00904	CbGpPWpGaD
Isoniazid—Body temperature increased—Calcitriol—psoriasis	0.000427	0.0022	CcSEcCtD
Isoniazid—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000425	0.00896	CbGpPWpGaD
Isoniazid—Dyspepsia—Acitretin—psoriasis	0.000423	0.00218	CcSEcCtD
Isoniazid—Decreased appetite—Acitretin—psoriasis	0.000418	0.00216	CcSEcCtD
Isoniazid—Malaise—Hydroxyurea—psoriasis	0.000417	0.00215	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Acitretin—psoriasis	0.000415	0.00214	CcSEcCtD
Isoniazid—Fatigue—Acitretin—psoriasis	0.000415	0.00214	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000414	0.00214	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—psoriasis	0.000406	0.00209	CcSEcCtD
Isoniazid—Hyperglycaemia—Cyclosporine—psoriasis	0.000406	0.00209	CcSEcCtD
Isoniazid—Convulsion—Hydroxyurea—psoriasis	0.000401	0.00207	CcSEcCtD
Isoniazid—Hypersensitivity—Calcitriol—psoriasis	0.000398	0.00205	CcSEcCtD
Isoniazid—Feeling abnormal—Acitretin—psoriasis	0.000396	0.00204	CcSEcCtD
Isoniazid—Hyperglycaemia—Mycophenolate mofetil—psoriasis	0.000396	0.00204	CcSEcCtD
Isoniazid—Diabetes mellitus—Prednisone—psoriasis	0.000396	0.00204	CcSEcCtD
Isoniazid—Neuropathy peripheral—Cyclosporine—psoriasis	0.000393	0.00203	CcSEcCtD
Isoniazid—Jaundice—Cyclosporine—psoriasis	0.000391	0.00202	CcSEcCtD
Isoniazid—Discomfort—Hydroxyurea—psoriasis	0.000389	0.00201	CcSEcCtD
Isoniazid—Asthenia—Calcitriol—psoriasis	0.000388	0.002	CcSEcCtD
Isoniazid—Psychotic disorder—Betamethasone—psoriasis	0.000386	0.00199	CcSEcCtD
Isoniazid—Psychotic disorder—Dexamethasone—psoriasis	0.000386	0.00199	CcSEcCtD
Isoniazid—Neuropathy peripheral—Mycophenolate mofetil—psoriasis	0.000384	0.00198	CcSEcCtD
Isoniazid—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000383	0.00807	CbGpPWpGaD
Isoniazid—Rash—Methoxsalen—psoriasis	0.000382	0.00197	CcSEcCtD
Isoniazid—Jaundice—Mycophenolate mofetil—psoriasis	0.000381	0.00197	CcSEcCtD
Isoniazid—Body temperature increased—Acitretin—psoriasis	0.00038	0.00196	CcSEcCtD
Isoniazid—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000379	0.00196	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—psoriasis	0.000372	0.00192	CcSEcCtD
Isoniazid—Thrombocytopenia—Hydroxyurea—psoriasis	0.00037	0.00191	CcSEcCtD
Isoniazid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000368	0.00776	CbGpPWpGaD
Isoniazid—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000365	0.00188	CcSEcCtD
Isoniazid—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000363	0.00765	CbGpPWpGaD
Isoniazid—Nausea—Methoxsalen—psoriasis	0.00036	0.00186	CcSEcCtD
Isoniazid—Hepatitis—Cyclosporine—psoriasis	0.00036	0.00186	CcSEcCtD
Isoniazid—Anorexia—Hydroxyurea—psoriasis	0.00036	0.00186	CcSEcCtD
Isoniazid—Ill-defined disorder—Mycophenolic acid—psoriasis	0.00036	0.00185	CcSEcCtD
Isoniazid—Neuropathy peripheral—Prednisolone—psoriasis	0.000358	0.00185	CcSEcCtD
Isoniazid—Gynaecomastia—Methotrexate—psoriasis	0.000355	0.00183	CcSEcCtD
Isoniazid—Hypersensitivity—Acitretin—psoriasis	0.000354	0.00183	CcSEcCtD
Isoniazid—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000353	0.00182	CcSEcCtD
Isoniazid—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000352	0.00742	CbGpPWpGaD
Isoniazid—Hepatitis—Mycophenolate mofetil—psoriasis	0.000351	0.00181	CcSEcCtD
Isoniazid—Neuropathy peripheral—Hydrocortisone—psoriasis	0.000349	0.0018	CcSEcCtD
Isoniazid—Malaise—Mycophenolic acid—psoriasis	0.000349	0.0018	CcSEcCtD
Isoniazid—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000349	0.00736	CbGpPWpGaD
Isoniazid—Asthenia—Acitretin—psoriasis	0.000345	0.00178	CcSEcCtD
Isoniazid—Vomiting—Calcitriol—psoriasis	0.000344	0.00177	CcSEcCtD
Isoniazid—Rash—Calcitriol—psoriasis	0.000341	0.00176	CcSEcCtD
Isoniazid—Lymphadenopathy—Methotrexate—psoriasis	0.000337	0.00174	CcSEcCtD
Isoniazid—Psychotic disorder—Prednisone—psoriasis	0.000336	0.00173	CcSEcCtD
Isoniazid—Convulsion—Mycophenolic acid—psoriasis	0.000336	0.00173	CcSEcCtD
Isoniazid—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000333	0.00703	CbGpPWpGaD
Isoniazid—Dyspepsia—Hydroxyurea—psoriasis	0.000332	0.00171	CcSEcCtD
Isoniazid—Diabetes mellitus—Methotrexate—psoriasis	0.000331	0.00171	CcSEcCtD
Isoniazid—Neuropathy peripheral—Triamcinolone—psoriasis	0.000329	0.0017	CcSEcCtD
Isoniazid—Decreased appetite—Hydroxyurea—psoriasis	0.000328	0.00169	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000326	0.00168	CcSEcCtD
Isoniazid—Discomfort—Mycophenolic acid—psoriasis	0.000326	0.00168	CcSEcCtD
Isoniazid—Fatigue—Hydroxyurea—psoriasis	0.000326	0.00168	CcSEcCtD
Isoniazid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000321	0.00678	CbGpPWpGaD
Isoniazid—Nausea—Calcitriol—psoriasis	0.000321	0.00166	CcSEcCtD
Isoniazid—Feeling abnormal—Hydroxyurea—psoriasis	0.000311	0.00161	CcSEcCtD
Isoniazid—Thrombocytopenia—Mycophenolic acid—psoriasis	0.00031	0.0016	CcSEcCtD
Isoniazid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000309	0.00652	CbGpPWpGaD
Isoniazid—Hyperglycaemia—Dexamethasone—psoriasis	0.000308	0.00159	CcSEcCtD
Isoniazid—Hyperglycaemia—Betamethasone—psoriasis	0.000308	0.00159	CcSEcCtD
Isoniazid—Vomiting—Acitretin—psoriasis	0.000306	0.00158	CcSEcCtD
Isoniazid—Vomiting—Fluocinolone Acetonide—psoriasis	0.000305	0.00157	CcSEcCtD
Isoniazid—Rash—Acitretin—psoriasis	0.000303	0.00156	CcSEcCtD
Isoniazid—Rash—Fluocinolone Acetonide—psoriasis	0.000302	0.00156	CcSEcCtD
Isoniazid—Anorexia—Mycophenolic acid—psoriasis	0.000301	0.00156	CcSEcCtD
Isoniazid—Neuropathy peripheral—Dexamethasone—psoriasis	0.000299	0.00154	CcSEcCtD
Isoniazid—Neuropathy peripheral—Betamethasone—psoriasis	0.000299	0.00154	CcSEcCtD
Isoniazid—Body temperature increased—Hydroxyurea—psoriasis	0.000298	0.00154	CcSEcCtD
Isoniazid—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000298	0.00629	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Cyclosporine—psoriasis	0.000291	0.0015	CcSEcCtD
Isoniazid—Nausea—Acitretin—psoriasis	0.000286	0.00147	CcSEcCtD
Isoniazid—Nausea—Fluocinolone Acetonide—psoriasis	0.000285	0.00147	CcSEcCtD
Isoniazid—Paraesthesia—Mycophenolic acid—psoriasis	0.000284	0.00147	CcSEcCtD
Isoniazid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000284	0.00599	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Mycophenolate mofetil—psoriasis	0.000284	0.00146	CcSEcCtD
Isoniazid—Malaise—Cyclosporine—psoriasis	0.000283	0.00146	CcSEcCtD
Isoniazid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000281	0.00593	CbGpPWpGaD
Isoniazid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000281	0.00592	CbGpPWpGaD
Isoniazid—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00028	0.00591	CbGpPWpGaD
Isoniazid—Dyspepsia—Mycophenolic acid—psoriasis	0.000278	0.00144	CcSEcCtD
Isoniazid—Hypersensitivity—Hydroxyurea—psoriasis	0.000278	0.00144	CcSEcCtD
Isoniazid—Malaise—Mycophenolate mofetil—psoriasis	0.000276	0.00142	CcSEcCtD
Isoniazid—Decreased appetite—Mycophenolic acid—psoriasis	0.000275	0.00142	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000273	0.00141	CcSEcCtD
Isoniazid—Fatigue—Mycophenolic acid—psoriasis	0.000273	0.00141	CcSEcCtD
Isoniazid—Convulsion—Cyclosporine—psoriasis	0.000272	0.0014	CcSEcCtD
Isoniazid—Asthenia—Hydroxyurea—psoriasis	0.000271	0.0014	CcSEcCtD
Isoniazid—Hyperglycaemia—Prednisone—psoriasis	0.000268	0.00138	CcSEcCtD
Isoniazid—Convulsion—Mycophenolate mofetil—psoriasis	0.000265	0.00137	CcSEcCtD
Isoniazid—Ill-defined disorder—Prednisolone—psoriasis	0.000265	0.00137	CcSEcCtD
Isoniazid—Discomfort—Cyclosporine—psoriasis	0.000264	0.00136	CcSEcCtD
Isoniazid—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000263	0.00556	CbGpPWpGaD
Isoniazid—Feeling abnormal—Mycophenolic acid—psoriasis	0.000261	0.00134	CcSEcCtD
Isoniazid—Neuropathy peripheral—Prednisone—psoriasis	0.00026	0.00134	CcSEcCtD
Isoniazid—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.00026	0.00548	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Hydrocortisone—psoriasis	0.000258	0.00133	CcSEcCtD
Isoniazid—Malaise—Prednisolone—psoriasis	0.000257	0.00133	CcSEcCtD
Isoniazid—Discomfort—Mycophenolate mofetil—psoriasis	0.000257	0.00133	CcSEcCtD
Isoniazid—Malaise—Hydrocortisone—psoriasis	0.000251	0.0013	CcSEcCtD
Isoniazid—Thrombocytopenia—Cyclosporine—psoriasis	0.00025	0.00129	CcSEcCtD
Isoniazid—Body temperature increased—Mycophenolic acid—psoriasis	0.00025	0.00129	CcSEcCtD
Isoniazid—NAT2—Metabolism—NDUFA5—psoriasis	0.00025	0.00527	CbGpPWpGaD
Isoniazid—Convulsion—Prednisolone—psoriasis	0.000247	0.00128	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—psoriasis	0.000246	0.00127	CcSEcCtD
Isoniazid—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000244	0.00126	CcSEcCtD
Isoniazid—Anorexia—Cyclosporine—psoriasis	0.000244	0.00126	CcSEcCtD
Isoniazid—Ill-defined disorder—Triamcinolone—psoriasis	0.000243	0.00126	CcSEcCtD
Isoniazid—Convulsion—Hydrocortisone—psoriasis	0.000241	0.00125	CcSEcCtD
Isoniazid—Vomiting—Hydroxyurea—psoriasis	0.00024	0.00124	CcSEcCtD
Isoniazid—Discomfort—Prednisolone—psoriasis	0.00024	0.00124	CcSEcCtD
Isoniazid—Rash—Hydroxyurea—psoriasis	0.000238	0.00123	CcSEcCtD
Isoniazid—Anorexia—Mycophenolate mofetil—psoriasis	0.000238	0.00123	CcSEcCtD
Isoniazid—Malaise—Triamcinolone—psoriasis	0.000237	0.00122	CcSEcCtD
Isoniazid—Discomfort—Hydrocortisone—psoriasis	0.000234	0.00121	CcSEcCtD
Isoniazid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00023	0.00485	CbGpPWpGaD
Isoniazid—Paraesthesia—Cyclosporine—psoriasis	0.00023	0.00119	CcSEcCtD
Isoniazid—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000228	0.0048	CbGpPWpGaD
Isoniazid—Convulsion—Triamcinolone—psoriasis	0.000227	0.00117	CcSEcCtD
Isoniazid—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000227	0.00479	CbGpPWpGaD
Isoniazid—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000227	0.00479	CbGpPWpGaD
Isoniazid—Asthenia—Mycophenolic acid—psoriasis	0.000227	0.00117	CcSEcCtD
Isoniazid—Dyspepsia—Cyclosporine—psoriasis	0.000225	0.00116	CcSEcCtD
Isoniazid—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000225	0.00474	CbGpPWpGaD
Isoniazid—Nausea—Hydroxyurea—psoriasis	0.000224	0.00116	CcSEcCtD
Isoniazid—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000224	0.00116	CcSEcCtD
Isoniazid—Decreased appetite—Cyclosporine—psoriasis	0.000222	0.00115	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000221	0.00114	CcSEcCtD
Isoniazid—Ill-defined disorder—Dexamethasone—psoriasis	0.000221	0.00114	CcSEcCtD
Isoniazid—Ill-defined disorder—Betamethasone—psoriasis	0.000221	0.00114	CcSEcCtD
Isoniazid—Discomfort—Triamcinolone—psoriasis	0.000221	0.00114	CcSEcCtD
Isoniazid—Fatigue—Cyclosporine—psoriasis	0.000221	0.00114	CcSEcCtD
Isoniazid—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00022	0.00113	CcSEcCtD
Isoniazid—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000217	0.00112	CcSEcCtD
Isoniazid—Anorexia—Hydrocortisone—psoriasis	0.000217	0.00112	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000215	0.00111	CcSEcCtD
Isoniazid—Malaise—Betamethasone—psoriasis	0.000215	0.00111	CcSEcCtD
Isoniazid—Malaise—Dexamethasone—psoriasis	0.000215	0.00111	CcSEcCtD
Isoniazid—NAT2—Metabolism—CYP2S1—psoriasis	0.000213	0.00448	CbGpPWpGaD
Isoniazid—Feeling abnormal—Cyclosporine—psoriasis	0.000211	0.00109	CcSEcCtD
Isoniazid—Paraesthesia—Prednisolone—psoriasis	0.000209	0.00108	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—psoriasis	0.000207	0.00107	CcSEcCtD
Isoniazid—Convulsion—Dexamethasone—psoriasis	0.000206	0.00106	CcSEcCtD
Isoniazid—Convulsion—Betamethasone—psoriasis	0.000206	0.00106	CcSEcCtD
Isoniazid—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000206	0.00106	CcSEcCtD
Isoniazid—Paraesthesia—Hydrocortisone—psoriasis	0.000204	0.00105	CcSEcCtD
Isoniazid—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000203	0.00429	CbGpPWpGaD
Isoniazid—Body temperature increased—Cyclosporine—psoriasis	0.000202	0.00104	CcSEcCtD
Isoniazid—Vomiting—Mycophenolic acid—psoriasis	0.000201	0.00104	CcSEcCtD
Isoniazid—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.0002	0.00423	CbGpPWpGaD
Isoniazid—Discomfort—Dexamethasone—psoriasis	0.0002	0.00103	CcSEcCtD
Isoniazid—Discomfort—Betamethasone—psoriasis	0.0002	0.00103	CcSEcCtD
Isoniazid—Dyspepsia—Hydrocortisone—psoriasis	0.0002	0.00103	CcSEcCtD
Isoniazid—Rash—Mycophenolic acid—psoriasis	0.000199	0.00103	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—psoriasis	0.000199	0.00103	CcSEcCtD
Isoniazid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000198	0.00417	CbGpPWpGaD
Isoniazid—Decreased appetite—Hydrocortisone—psoriasis	0.000198	0.00102	CcSEcCtD
Isoniazid—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000197	0.00102	CcSEcCtD
Isoniazid—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000197	0.00416	CbGpPWpGaD
Isoniazid—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000196	0.00101	CcSEcCtD
Isoniazid—Fatigue—Hydrocortisone—psoriasis	0.000196	0.00101	CcSEcCtD
Isoniazid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000196	0.00413	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Prednisone—psoriasis	0.000192	0.000992	CcSEcCtD
Isoniazid—Paraesthesia—Triamcinolone—psoriasis	0.000192	0.000992	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisolone—psoriasis	0.000192	0.00099	CcSEcCtD
Isoniazid—Thrombocytopenia—Dexamethasone—psoriasis	0.00019	0.000981	CcSEcCtD
Isoniazid—Thrombocytopenia—Betamethasone—psoriasis	0.00019	0.000981	CcSEcCtD
Isoniazid—Hypersensitivity—Cyclosporine—psoriasis	0.000188	0.000972	CcSEcCtD
Isoniazid—Dyspepsia—Triamcinolone—psoriasis	0.000188	0.000972	CcSEcCtD
Isoniazid—Nausea—Mycophenolic acid—psoriasis	0.000188	0.000969	CcSEcCtD
Isoniazid—Feeling abnormal—Hydrocortisone—psoriasis	0.000187	0.000967	CcSEcCtD
Isoniazid—Malaise—Prednisone—psoriasis	0.000187	0.000964	CcSEcCtD
Isoniazid—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000187	0.00394	CbGpPWpGaD
Isoniazid—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000186	0.00391	CbGpPWpGaD
Isoniazid—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000185	0.00391	CbGpPWpGaD
Isoniazid—Anorexia—Dexamethasone—psoriasis	0.000185	0.000955	CcSEcCtD
Isoniazid—Anorexia—Betamethasone—psoriasis	0.000185	0.000955	CcSEcCtD
Isoniazid—Fatigue—Triamcinolone—psoriasis	0.000185	0.000952	CcSEcCtD
Isoniazid—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000184	0.00389	CbGpPWpGaD
Isoniazid—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000184	0.000949	CcSEcCtD
Isoniazid—Asthenia—Cyclosporine—psoriasis	0.000184	0.000947	CcSEcCtD
Isoniazid—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000183	0.00385	CbGpPWpGaD
Isoniazid—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000181	0.00382	CbGpPWpGaD
Isoniazid—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.00018	0.0038	CbGpPWpGaD
Isoniazid—Body temperature increased—Hydrocortisone—psoriasis	0.00018	0.000927	CcSEcCtD
Isoniazid—Convulsion—Prednisone—psoriasis	0.00018	0.000927	CcSEcCtD
Isoniazid—Asthenia—Mycophenolate mofetil—psoriasis	0.000179	0.000924	CcSEcCtD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000176	0.00372	CbGpPWpGaD
Isoniazid—Feeling abnormal—Triamcinolone—psoriasis	0.000176	0.00091	CcSEcCtD
Isoniazid—Paraesthesia—Dexamethasone—psoriasis	0.000174	0.0009	CcSEcCtD
Isoniazid—Paraesthesia—Betamethasone—psoriasis	0.000174	0.0009	CcSEcCtD
Isoniazid—Discomfort—Prednisone—psoriasis	0.000174	0.0009	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisolone—psoriasis	0.000172	0.000885	CcSEcCtD
Isoniazid—Dyspepsia—Betamethasone—psoriasis	0.000171	0.000882	CcSEcCtD
Isoniazid—Dyspepsia—Dexamethasone—psoriasis	0.000171	0.000882	CcSEcCtD
Isoniazid—Body temperature increased—Triamcinolone—psoriasis	0.000169	0.000873	CcSEcCtD
Isoniazid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000169	0.00356	CbGpPWpGaD
Isoniazid—Decreased appetite—Betamethasone—psoriasis	0.000169	0.000871	CcSEcCtD
Isoniazid—Decreased appetite—Dexamethasone—psoriasis	0.000169	0.000871	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Betamethasone—psoriasis	0.000168	0.000865	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000168	0.000865	CcSEcCtD
Isoniazid—Hypersensitivity—Hydrocortisone—psoriasis	0.000168	0.000864	CcSEcCtD
Isoniazid—Fatigue—Betamethasone—psoriasis	0.000167	0.000864	CcSEcCtD
Isoniazid—Fatigue—Dexamethasone—psoriasis	0.000167	0.000864	CcSEcCtD
Isoniazid—Asthenia—Hydrocortisone—psoriasis	0.000163	0.000842	CcSEcCtD
Isoniazid—Vomiting—Cyclosporine—psoriasis	0.000163	0.000839	CcSEcCtD
Isoniazid—Rash—Cyclosporine—psoriasis	0.000161	0.000832	CcSEcCtD
Isoniazid—Anorexia—Prednisone—psoriasis	0.000161	0.000832	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—psoriasis	0.000161	0.000829	CcSEcCtD
Isoniazid—Feeling abnormal—Dexamethasone—psoriasis	0.00016	0.000826	CcSEcCtD
Isoniazid—Feeling abnormal—Betamethasone—psoriasis	0.00016	0.000826	CcSEcCtD
Isoniazid—Vomiting—Mycophenolate mofetil—psoriasis	0.000159	0.000819	CcSEcCtD
Isoniazid—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000158	0.00334	CbGpPWpGaD
Isoniazid—Hypersensitivity—Triamcinolone—psoriasis	0.000158	0.000814	CcSEcCtD
Isoniazid—Rash—Mycophenolate mofetil—psoriasis	0.000157	0.000812	CcSEcCtD
Isoniazid—Malaise—Methotrexate—psoriasis	0.000156	0.000806	CcSEcCtD
Isoniazid—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000156	0.00329	CbGpPWpGaD
Isoniazid—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000156	0.00329	CbGpPWpGaD
Isoniazid—Asthenia—Triamcinolone—psoriasis	0.000154	0.000792	CcSEcCtD
Isoniazid—Body temperature increased—Dexamethasone—psoriasis	0.000154	0.000792	CcSEcCtD
Isoniazid—Body temperature increased—Betamethasone—psoriasis	0.000154	0.000792	CcSEcCtD
Isoniazid—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000154	0.00324	CbGpPWpGaD
Isoniazid—Nausea—Cyclosporine—psoriasis	0.000152	0.000784	CcSEcCtD
Isoniazid—Paraesthesia—Prednisone—psoriasis	0.000152	0.000784	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—psoriasis	0.00015	0.000774	CcSEcCtD
Isoniazid—Dyspepsia—Prednisone—psoriasis	0.000149	0.000768	CcSEcCtD
Isoniazid—Nausea—Mycophenolate mofetil—psoriasis	0.000148	0.000765	CcSEcCtD
Isoniazid—Decreased appetite—Prednisone—psoriasis	0.000147	0.000759	CcSEcCtD
Isoniazid—Rash—Prednisolone—psoriasis	0.000147	0.000757	CcSEcCtD
Isoniazid—Fatigue—Prednisone—psoriasis	0.000146	0.000752	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—psoriasis	0.000146	0.000752	CcSEcCtD
Isoniazid—Vomiting—Hydrocortisone—psoriasis	0.000145	0.000746	CcSEcCtD
Isoniazid—Rash—Hydrocortisone—psoriasis	0.000143	0.00074	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisone—psoriasis	0.000139	0.000719	CcSEcCtD
Isoniazid—Asthenia—Dexamethasone—psoriasis	0.000139	0.000719	CcSEcCtD
Isoniazid—Asthenia—Betamethasone—psoriasis	0.000139	0.000719	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—psoriasis	0.000138	0.000714	CcSEcCtD
Isoniazid—Nausea—Prednisolone—psoriasis	0.000138	0.000713	CcSEcCtD
Isoniazid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000138	0.00291	CbGpPWpGaD
Isoniazid—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000137	0.00288	CbGpPWpGaD
Isoniazid—Vomiting—Triamcinolone—psoriasis	0.000136	0.000702	CcSEcCtD
Isoniazid—Nausea—Hydrocortisone—psoriasis	0.000135	0.000697	CcSEcCtD
Isoniazid—Rash—Triamcinolone—psoriasis	0.000135	0.000696	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—psoriasis	0.000135	0.000695	CcSEcCtD
Isoniazid—Body temperature increased—Prednisone—psoriasis	0.000134	0.00069	CcSEcCtD
Isoniazid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00013	0.00275	CbGpPWpGaD
Isoniazid—Nausea—Triamcinolone—psoriasis	0.000127	0.000656	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—psoriasis	0.000127	0.000655	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisone—psoriasis	0.000125	0.000643	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—psoriasis	0.000124	0.000642	CcSEcCtD
Isoniazid—Vomiting—Dexamethasone—psoriasis	0.000124	0.000637	CcSEcCtD
Isoniazid—Vomiting—Betamethasone—psoriasis	0.000124	0.000637	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—psoriasis	0.000123	0.000634	CcSEcCtD
Isoniazid—Rash—Dexamethasone—psoriasis	0.000122	0.000632	CcSEcCtD
Isoniazid—Rash—Betamethasone—psoriasis	0.000122	0.000632	CcSEcCtD
Isoniazid—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000122	0.00258	CbGpPWpGaD
Isoniazid—Gastrointestinal disorder—Methotrexate—psoriasis	0.000122	0.00063	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—psoriasis	0.000122	0.000629	CcSEcCtD
Isoniazid—Asthenia—Prednisone—psoriasis	0.000121	0.000626	CcSEcCtD
Isoniazid—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000121	0.00254	CbGpPWpGaD
Isoniazid—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000119	0.00251	CbGpPWpGaD
Isoniazid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000118	0.00248	CbGpPWpGaD
Isoniazid—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000117	0.00247	CbGpPWpGaD
Isoniazid—Feeling abnormal—Methotrexate—psoriasis	0.000117	0.000601	CcSEcCtD
Isoniazid—Nausea—Betamethasone—psoriasis	0.000115	0.000595	CcSEcCtD
Isoniazid—Nausea—Dexamethasone—psoriasis	0.000115	0.000595	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—psoriasis	0.000112	0.000577	CcSEcCtD
Isoniazid—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000108	0.00227	CbGpPWpGaD
Isoniazid—Vomiting—Prednisone—psoriasis	0.000108	0.000555	CcSEcCtD
Isoniazid—Rash—Prednisone—psoriasis	0.000107	0.00055	CcSEcCtD
Isoniazid—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000105	0.00222	CbGpPWpGaD
Isoniazid—Hypersensitivity—Methotrexate—psoriasis	0.000104	0.000537	CcSEcCtD
Isoniazid—NAT2—Metabolism—CARM1—psoriasis	0.000104	0.00219	CbGpPWpGaD
Isoniazid—Asthenia—Methotrexate—psoriasis	0.000101	0.000523	CcSEcCtD
Isoniazid—Nausea—Prednisone—psoriasis	0.0001	0.000518	CcSEcCtD
Isoniazid—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	9.13e-05	0.00193	CbGpPWpGaD
Isoniazid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.09e-05	0.00192	CbGpPWpGaD
Isoniazid—Vomiting—Methotrexate—psoriasis	8.99e-05	0.000464	CcSEcCtD
Isoniazid—Rash—Methotrexate—psoriasis	8.91e-05	0.00046	CcSEcCtD
Isoniazid—Nausea—Methotrexate—psoriasis	8.4e-05	0.000433	CcSEcCtD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.59e-05	0.0016	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NDUFA5—psoriasis	6.7e-05	0.00141	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.56e-05	0.00138	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—CAT—psoriasis	6.38e-05	0.00135	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.31e-05	0.00133	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.73e-05	0.00121	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CYP2S1—psoriasis	5.7e-05	0.0012	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NDUFA5—psoriasis	5.3e-05	0.00112	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—APOE—psoriasis	4.96e-05	0.00105	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.91e-05	0.00104	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.91e-05	0.00104	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NDUFA5—psoriasis	4.58e-05	0.000966	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP2S1—psoriasis	4.5e-05	0.00095	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PPARG—psoriasis	4.32e-05	0.000911	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.27e-05	0.000901	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NDUFA5—psoriasis	4.09e-05	0.000862	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP2S1—psoriasis	3.89e-05	0.000821	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.81e-05	0.000804	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NDUFA5—psoriasis	3.76e-05	0.000793	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NDUFA5—psoriasis	3.73e-05	0.000786	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP2S1—psoriasis	3.48e-05	0.000733	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.48e-05	0.000733	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP2S1—psoriasis	3.2e-05	0.000674	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NDUFA5—psoriasis	3.18e-05	0.000672	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP2S1—psoriasis	3.17e-05	0.000668	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.97e-05	0.000626	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CARM1—psoriasis	2.78e-05	0.000587	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP2S1—psoriasis	2.71e-05	0.000571	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NDUFA5—psoriasis	2.46e-05	0.000518	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CARM1—psoriasis	2.2e-05	0.000464	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2S1—psoriasis	2.09e-05	0.000441	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.04e-05	0.00043	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CARM1—psoriasis	1.9e-05	0.000401	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.82e-05	0.000384	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.78e-05	0.000375	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CAT—psoriasis	1.71e-05	0.000361	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CARM1—psoriasis	1.7e-05	0.000358	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.66e-05	0.00035	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.59e-05	0.000335	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CARM1—psoriasis	1.56e-05	0.000329	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CARM1—psoriasis	1.55e-05	0.000326	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.45e-05	0.000305	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.42e-05	0.000299	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CAT—psoriasis	1.35e-05	0.000285	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—APOE—psoriasis	1.33e-05	0.000281	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CARM1—psoriasis	1.32e-05	0.000279	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.24e-05	0.000261	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CAT—psoriasis	1.17e-05	0.000247	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PPARG—psoriasis	1.16e-05	0.000244	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—APOE—psoriasis	1.05e-05	0.000222	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CAT—psoriasis	1.04e-05	0.00022	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CARM1—psoriasis	1.02e-05	0.000215	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CAT—psoriasis	9.6e-06	0.000203	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CAT—psoriasis	9.52e-06	0.000201	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PPARG—psoriasis	9.16e-06	0.000193	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—APOE—psoriasis	9.09e-06	0.000192	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CAT—psoriasis	8.13e-06	0.000172	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—APOE—psoriasis	8.11e-06	0.000171	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PPARG—psoriasis	7.92e-06	0.000167	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—APOE—psoriasis	7.46e-06	0.000157	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—APOE—psoriasis	7.4e-06	0.000156	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PPARG—psoriasis	7.07e-06	0.000149	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PPARG—psoriasis	6.5e-06	0.000137	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PPARG—psoriasis	6.44e-06	0.000136	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—APOE—psoriasis	6.32e-06	0.000133	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CAT—psoriasis	6.28e-06	0.000132	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PPARG—psoriasis	5.51e-06	0.000116	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—APOE—psoriasis	4.88e-06	0.000103	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PPARG—psoriasis	4.25e-06	8.96e-05	CbGpPWpGaD
